Boston Total Other Income Expense Net vs Cost Of Revenue Analysis
BSX Stock | USD 74.17 0.38 0.51% |
Boston Scientific financial indicator trend analysis is way more than just evaluating Boston Scientific Corp prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Boston Scientific Corp is a good investment. Please check the relationship between Boston Scientific Total Other Income Expense Net and its Cost Of Revenue accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Boston Scientific Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state.
Total Other Income Expense Net vs Cost Of Revenue
Total Other Income Expense Net vs Cost Of Revenue Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Boston Scientific Corp Total Other Income Expense Net account and Cost Of Revenue. At this time, the significance of the direction appears to have no relationship.
The correlation between Boston Scientific's Total Other Income Expense Net and Cost Of Revenue is 0.07. Overlapping area represents the amount of variation of Total Other Income Expense Net that can explain the historical movement of Cost Of Revenue in the same time period over historical financial statements of Boston Scientific Corp, assuming nothing else is changed. The correlation between historical values of Boston Scientific's Total Other Income Expense Net and Cost Of Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Other Income Expense Net of Boston Scientific Corp are associated (or correlated) with its Cost Of Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Cost Of Revenue has no effect on the direction of Total Other Income Expense Net i.e., Boston Scientific's Total Other Income Expense Net and Cost Of Revenue go up and down completely randomly.
Correlation Coefficient | 0.07 |
Relationship Direction | Positive |
Relationship Strength | Insignificant |
Total Other Income Expense Net
Cost Of Revenue
Cost of Revenue is found on Boston Scientific Corp income statement and represents the costs associated with goods and services Boston Scientific provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.Most indicators from Boston Scientific's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Boston Scientific Corp current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Boston Scientific Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state. At this time, Boston Scientific's Selling General Administrative is fairly stable compared to the past year. Tax Provision is likely to rise to about 679.4 M in 2024, whereas Sales General And Administrative To Revenue is likely to drop 0.29 in 2024.
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 8.1B | 8.7B | 9.9B | 10.4B | Total Revenue | 11.9B | 12.7B | 14.2B | 15.0B |
Boston Scientific fundamental ratios Correlations
Click cells to compare fundamentals
Boston Scientific Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Boston Scientific fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 30.6B | 30.8B | 32.2B | 32.5B | 35.1B | 36.9B | |
Short Long Term Debt Total | 10.3B | 9.5B | 9.5B | 9.3B | 9.5B | 10.0B | |
Other Current Liab | 2.8B | 3.0B | 3.0B | 2.7B | 3.2B | 3.4B | |
Total Current Liabilities | 4.9B | 3.7B | 4.3B | 3.8B | 4.9B | 5.2B | |
Total Stockholder Equity | 13.9B | 15.3B | 16.6B | 17.6B | 19.3B | 20.2B | |
Property Plant And Equipment Net | 2.4B | 2.5B | 2.7B | 2.8B | 3.3B | 3.5B | |
Net Debt | 10.1B | 7.8B | 7.5B | 8.4B | 8.6B | 9.1B | |
Retained Earnings | (2.3B) | (2.4B) | (1.4B) | (750M) | 819M | 860.0M | |
Accounts Payable | 542M | 513M | 794M | 862M | 942M | 989.1M | |
Non Current Assets Total | 25.9B | 24.1B | 25.9B | 26.7B | 28.6B | 30.1B | |
Non Currrent Assets Other | 735M | 545M | 563M | 707M | 679M | 713.0M | |
Net Receivables | 1.9B | 1.5B | 1.8B | 2.0B | 2.2B | 2.3B | |
Common Stock Shares Outstanding | 1.4B | 1.4B | 1.4B | 1.4B | 1.5B | 1.2B | |
Liabilities And Stockholders Equity | 30.6B | 30.8B | 32.2B | 32.5B | 34.9B | 36.6B | |
Non Current Liabilities Total | 11.8B | 11.8B | 11.3B | 11.1B | 10.7B | 6.2B | |
Inventory | 1.6B | 1.4B | 1.6B | 1.9B | 2.5B | 2.6B | |
Other Current Assets | 324M | 410M | 385M | 350M | 333M | 426.3M | |
Other Stockholder Equity | 15.8B | 17.5B | 17.7B | 18.0B | 18.4B | 10.0B | |
Total Liab | 16.7B | 15.5B | 15.6B | 14.9B | 15.6B | 8.6B | |
Property Plant And Equipment Gross | 2.4B | 2.5B | 2.3B | 2.4B | 6.8B | 7.1B | |
Total Current Assets | 4.7B | 6.7B | 6.3B | 5.8B | 6.5B | 3.3B | |
Accumulated Other Comprehensive Income | 270M | 207M | 263M | 269M | 49M | 51.5M | |
Short Term Debt | 1.4B | 13M | 261M | 20M | 531M | 417.5M | |
Intangible Assets | 7.9B | 5.9B | 6.1B | 5.9B | 6.0B | 4.9B | |
Other Liab | 3.0B | 2.2B | 2.1B | 1.8B | 2.1B | 1.9B | |
Other Assets | (2M) | 4.6B | 3M | 2M | (1M) | 950K | |
Long Term Debt | 8.6B | 9.1B | 8.8B | 8.9B | 8.6B | 5.6B | |
Good Will | 10.2B | 10.0B | 12.0B | 12.9B | 14.4B | 8.6B | |
Property Plant Equipment | 2.1B | 2.1B | 2.3B | 2.8B | 3.3B | 1.7B | |
Current Deferred Revenue | 144M | 138M | 208M | 220M | 266M | 333.1M | |
Net Tangible Assets | (4.2B) | 9.4B | (1.7B) | 11.7B | 13.4B | 14.1B | |
Retained Earnings Total Equity | (2.3B) | (2.4B) | (1.4B) | (750M) | (862.5M) | (905.6M) | |
Long Term Debt Total | 8.6B | 9.1B | 8.8B | 8.9B | 10.3B | 6.6B |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.C | Citigroup | |
CRM | Salesforce | |
MSFT | Microsoft |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Boston Scientific Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Complementary Tools for Boston Stock analysis
When running Boston Scientific's price analysis, check to measure Boston Scientific's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Boston Scientific is operating at the current time. Most of Boston Scientific's value examination focuses on studying past and present price action to predict the probability of Boston Scientific's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Boston Scientific's price. Additionally, you may evaluate how the addition of Boston Scientific to your portfolios can decrease your overall portfolio volatility.
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Stocks Directory Find actively traded stocks across global markets |
Is Boston Scientific's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Boston Scientific. If investors know Boston will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Boston Scientific listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.579 | Earnings Share 1.19 | Revenue Per Share 10.065 | Quarterly Revenue Growth 0.138 | Return On Assets 0.0454 |
The market value of Boston Scientific Corp is measured differently than its book value, which is the value of Boston that is recorded on the company's balance sheet. Investors also form their own opinion of Boston Scientific's value that differs from its market value or its book value, called intrinsic value, which is Boston Scientific's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Boston Scientific's market value can be influenced by many factors that don't directly affect Boston Scientific's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Boston Scientific's value and its price as these two are different measures arrived at by different means. Investors typically determine if Boston Scientific is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Boston Scientific's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.